CHICAGO, May 21, 2024 (GLOBE NEWSWIRE) — Amplify ETFs announces the launch of the Amplify…
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
BALA CYNWYD, Pa., May 20, 2024 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR),…
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., May 20, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle…
Hims & Hers Stock Rockets Higher On Weight Loss Medication Deal
One of healthcare’s hottest names keeps climbing Today, the share price of Hims & Hers…
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics,…
NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease
SNK01, a cryopreserved, autologous enhanced natural killer cell therapy, delivered in highest dose to date,…
BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn
The data will be presented at the Annual ALS Drug Development Summit, which is focused…
TREEFROG PRESENTS DATA FROM THEIR PARKINSON’S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON’S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON
BORDEAUX, France, May 20, 2024 /PRNewswire/ — TreeFrog Therapeutics will participate for the first time at the…
PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation
– European Commission decides against adoption of negative opinion – – Translarna authorization remains active in Europe –…
Compugen Reports First Quarter 2024 Results
HOLON, Israel, May 20, 2024 /PRNewswire/ — Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer…